Literature DB >> 21527846

Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells.

Ana Burgeiro1, Consuelo Gajate, El Habib Dakir, Janny A Villa-Pulgarín, Paulo J Oliveira, Faustino Mollinedo.   

Abstract

The natural isoquinoline alkaloid berberine exhibits a wide spectrum of biological activities including antitumor activity, but its mechanism of action remains to be fully elucidated. Here, we report that berberine induced apoptosis in human melanoma cells, through a process that involved mitochondria and caspase activation. Berberine-induced activation of a number of caspases, including caspases 3, 4, 7, 8, and 9. Pan-caspase inhibitor, z-VAD-fmk, and caspase-8 and caspase-9 inhibitors prevented apoptosis. Berberine also led to the generation of the p20 cleavage fragment of BAP31, involved in directing proapoptotic signals between the endoplasmic reticulum and the mitochondria. Treatment of SK-MEL-2 melanoma cells with berberine induced disruption of the mitochondrial transmembrane potential, release of cytochrome c and apoptosis-inducing factor from the mitochondria to the cytosol, generation of reactive oxygen species (ROS), and a decreased ATP/ADP ratio. Overexpression of bcl-xL by gene transfer prevented berberine-induced cell death, mitochondrial transmembrane potential loss, and cytochrome c and apoptosis-inducing factor release, but not ROS generation. N-acetyl-L-cysteine inhibited the production of ROS, but did not abrogate the berberine-induced apoptosis. Inhibition of extracellular signal-regulated kinase (ERK) phosphorylation, by using the mitogen-activated protein kinase/ERK kinase inhibitor PD98059, and reduction of B-RAF levels by silencing RNA induced cell death of SK-MEL-2 cells, and diminished the berberine concentration required to promote apoptosis. These data show that berberine-induced apoptosis in melanoma cells involves mitochondria and caspase activation, but ROS generation was not essential. Our results indicate that inhibition of B-RAF/ERK survival signaling facilitates the cell death response triggered by berberine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527846     DOI: 10.1097/CAD.0b013e32834438f6

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  13 in total

1.  Novel therapeutic approaches for pancreatic cancer by combined targeting of RAF→MEK→ERK signaling and autophagy survival response.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  Ann Transl Med       Date:  2019-07

2.  Neuroprotective activities of curcumin and quercetin with potential relevance to mitochondrial dysfunction induced by oxaliplatin.

Authors:  Mohammad Waseem; Suhel Parvez
Journal:  Protoplasma       Date:  2015-05-29       Impact factor: 3.356

3.  Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with Onivyde for pancreatic cancer.

Authors:  Xue Wang; Ying Liu; Wanjia Xu; Lirui Jia; Dongxu Chi; Jiang Yu; Jiamei Wang; Zhonggui He; Xiaohong Liu; Yongjun Wang
Journal:  Drug Deliv Transl Res       Date:  2021-01-15       Impact factor: 4.617

4.  Targeting TRAP1 as a downstream effector of BRAF cytoprotective pathway: a novel strategy for human BRAF-driven colorectal carcinoma.

Authors:  Valentina Condelli; Francesca Maddalena; Lorenza Sisinni; Giacomo Lettini; Danilo Swann Matassa; Annamaria Piscazzi; Giuseppe Palladino; Maria Rosaria Amoroso; Franca Esposito; Matteo Landriscina
Journal:  Oncotarget       Date:  2015-09-08

5.  p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.

Authors:  Fang Zheng; Qin Tang; JingJing Wu; ShunYu Zhao; ZhanYang Liang; Liuning Li; WanYin Wu; Swei Hann
Journal:  J Exp Clin Cancer Res       Date:  2014-04-26

Review 6.  Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Authors:  Xuanbin Wang; Yibin Feng; Ning Wang; Fan Cheung; Hor Yue Tan; Sen Zhong; Charlie Li; Seiichi Kobayashi
Journal:  Biomed Res Int       Date:  2014-10-14       Impact factor: 3.411

7.  Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment.

Authors:  Parham Jabbarzadeh Kaboli; Patimah Ismail; King-Hwa Ling
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

8.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

9.  Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor.

Authors:  Lihong Wang; Liping Liu; Yan Shi; Hanwei Cao; Rupesh Chaturvedi; M Wade Calcutt; Tianhui Hu; Xiubao Ren; Keith T Wilson; D Brent Polk; Fang Yan
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

10.  Functional inhibition of lactate dehydrogenase suppresses pancreatic adenocarcinoma progression.

Authors:  Chien-Shan Cheng; Hor-Yue Tan; Ning Wang; Lianyu Chen; Zhiqiang Meng; Zhen Chen; Yibin Feng
Journal:  Clin Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.